
Udc Pharma Private Limited
About Udc Pharma Private Limited
Data last updated:
Udc Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 04 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U85100PN2016PTC166665. Its GSTIN is 27AABCU9925C1Z9 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.5 Lakh. It is led by directors Amol Manik Pawar and Shankar Raghunath Chavan.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Yashwin Flat No. 1005 Sr.No 25 – 26 Behind Teerth Tower, Pune, Maharashtra, India – 411021.
As per the financials filed for FY 2020, the company reported a revenue of ₹23.38 Lakh, a decline of 36% compared to the previous year. For the same year it recorded a net profit of ₹14,214 (net margin 0.6%) and EBITDA of ₹26,010 (EBITDA margin 1.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Udc Pharma Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressYashwin Flat No. 1005 Sr.No 25 – 26 Behind Teerth Tower, Pune, Maharashtra, India – 411021
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Udc Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Udc Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Udc Pharma Private Limited, buy the company report.
Financials of Udc Pharma Private Limited
FY 2020 filings availableUdc Pharma Private Limited reported revenue of ₹23.38 Lakh (down 36% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 36% in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹26,010 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹14,214 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.1% | |||
| Net Profit Margin | 0.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Udc Pharma Private Limited, buy the company report.
Board of directors of Udc Pharma Private Limited
Udc Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amol Manik Pawar | Director | 19 Aug 2021 | 5 Years 2 Months | Current |
| Shankar Raghunath Chavan | Director | 04 Oct 2016 | 10 Years 1 Months | Current |
Peer comparison
Udc Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| I. C. Medicare Private Limited | ₹23.46 Lakh (FY 2019) | 22.0% | New Delhi, Delhi, India | |||
| Aumcropcare Solutions Private Limited | ₹23.46 Lakh (FY 2025) | 38.0% | Coimbatore, Tamil Nadu, India | |||
| G.F.A Chemicals and Fertilisers Private Limited | ₹23.45 Lakh (FY 2024) | 150.0% | Idukki, Kerala, India | |||
| Glydous Pharmaceuticals Private Limited | ₹23.42 Lakh (FY 2025) | -15.0% | Gorakhpur, Uttar Pradesh, India | |||
| Rantas Pharmaceuticals Private Limited | ₹23.39 Lakh (FY 2025) | 6.0% | Solan, Himachal Pradesh, India | |||
| Udc Pharma Private Limitedthis company | ₹23.38 Lakh (FY 2020) | ₹14,214 | 0.6% | -36.0% | Pune, Maharashtra, India | |
| Kinesia Biotech Private Limited | ₹23.38 Lakh (FY 2023) | Jaipur, Rajasthan, India | ||||
| Destgen Life Science Private Limited | ₹23.35 Lakh (FY 2024) | -56.0% | Pune, Maharashtra, India | |||
| Mac Biofarming Private Limited | ₹23.3 Lakh (FY 2020) | Agra, Uttar Pradesh, India | ||||
| Exarmed Pharma Private Limited | ₹23.29 Lakh (FY 2023) | 109.0% | Gujvail, Telangana, India | |||
| Phamdoc Life Care Private Limited | ₹23.26 Lakh (FY 2024) | Hassan, Karnataka, India |
To see the full peer comparison of Udc Pharma Private Limited, buy the company report.
Auditor
Udc Pharma Private Limited is audited by SANJAY P KUMAR & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY P KUMAR & ASSOCIATES | FY 2017 | 141887W |
Shareholding
The shareholding of Udc Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Udc Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Udc Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Udc Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Udc Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCU9925C1Z9 | Maharashtra | Active | 12 Aug 2017 |
To see the full GST registrations and return filing status of Udc Pharma Private Limited, buy the company report.
Recent activity
Udc Pharma Private Limited has 6 board changes on record since 2016: 2 appointments and 4 cessations. The latest: Amol Manik Pawar was appointed as Director on 19 Aug 2021.
Frequently asked questions
Udc Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 04 October 2016 (10+ years old) and is registered under CIN U85100PN2016PTC166665.
Udc Pharma has 2 current directors:
- Amol Manik Pawar - Director
- Shankar Raghunath Chavan - Director
The latest financial statements of Udc Pharma on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Udc Pharma is 27AABCU9925C1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Udc Pharma is U85100PN2016PTC166665. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Udc Pharma was incorporated on 04 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Udc Pharma by revenue are I. C. Medicare Private Limited, Aumcropcare Solutions Private Limited, G.F.A Chemicals and Fertilisers Private Limited, Glydous Pharmaceuticals Private Limited, Rantas Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amol Manik Pawar was appointed as Director on 19 Aug 2021. Vishvas Baliram Gawate ceased to be Director on 19 Aug 2021. Yogesh Hiralal Lade ceased to be Director on 19 Aug 2021. Udc Pharma has 6 board changes on record in total.
The registered office of Udc Pharma is at Yashwin Flat No. 1005 Sr.No 25 – 26 Behind Teerth Tower, Pune, Maharashtra, India – 411021.
Udc Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Udc Pharma is compliant as of 31 July 2026. The company is actively filing with the Registrar of Companies.

